These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6997638)

  • 21. Marrow-thymus cell radiation chimeras accept allogeneic rat hearts.
    Dittmer J; Bennett M
    Transplant Proc; 1977 Mar; 9(1):895-900. PubMed ID: 325820
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic graft-versus-host disease in the rat radiation chimera. I. Clinical features, hematology, histology, and immunopathology in long-term chimeras.
    Beschorner WE; Tutschka PJ; Santos GW
    Transplantation; 1982 Apr; 33(4):393-9. PubMed ID: 7041364
    [No Abstract]   [Full Text] [Related]  

  • 23. Cellular basis of acquired immunologic tolerance following total bowel transplantation in rats. I. Relation between donor lymphocyte chimerism and host-cell-mediated immunity.
    Masaki Y; Kimura H; Oohara T
    Transplant Proc; 1995 Apr; 27(2):1585-8. PubMed ID: 7536971
    [No Abstract]   [Full Text] [Related]  

  • 24. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow transplantation in acute leukemia.
    Santos GW; Kaizer H
    Semin Hematol; 1982 Jul; 19(3):227-39. PubMed ID: 7051290
    [No Abstract]   [Full Text] [Related]  

  • 26. The cellular basis of transplantation tolerance.
    Elkins WL
    Transplant Proc; 1973 Mar; 5(1):685-9. PubMed ID: 4144461
    [No Abstract]   [Full Text] [Related]  

  • 27. Bone-marrow transplantation in France, 1958-1973.
    Mathé G; Schwarzenberg L
    Transplant Proc; 1974 Dec; 6(4):335-43. PubMed ID: 4155150
    [No Abstract]   [Full Text] [Related]  

  • 28. T-cell development and susceptibility to cyclosporine A-induced autoimmunity in MHC-matched bone marrow/thymus chimeras.
    Damoiseaux J; van de Gaar J; van der Heijden H; van Breda Vriesman P
    Transplant Proc; 1999 May; 31(3):1579-80. PubMed ID: 10331009
    [No Abstract]   [Full Text] [Related]  

  • 29. Specific inactivation of lymphoid cells in bone marrow grafts.
    Müller-Ruchholtz W; Müller-Hermelink HK; Sonntag HG
    Transplant Proc; 1973 Mar; 5(1):877-80. PubMed ID: 4144468
    [No Abstract]   [Full Text] [Related]  

  • 30. Partial tolerance and immunity after adoptive abrogation of transplantation tolerance in the rat.
    Elkins WL; Adams JS; Fox DH; Wilson DB; Stuart FP
    Cell Immunol; 1973 Dec; 9(3):412-25. PubMed ID: 4148477
    [No Abstract]   [Full Text] [Related]  

  • 31. The relative roles of MHC and non-MHC antigens in bone marrow transplantation in rats. Graft acceptance and antigenic expression on donor red blood cells.
    Pinto M; Gill TJ; Kunz HW; Dixon-McCarthy BD
    Transplantation; 1983 Jun; 35(6):607-11. PubMed ID: 6346598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune status of allogeneic radiation chimeras.
    Gengozian N; Congdon CC; Allen EA; Toya RE
    Transplant Proc; 1971 Mar; 3(1):434-6. PubMed ID: 4398502
    [No Abstract]   [Full Text] [Related]  

  • 33. Parental-F1 hybrid bone marrow chimeras: high incidence of donor-type lymphomas.
    Cole LJ; Nowell PC
    Proc Soc Exp Biol Med; 1970 Jul; 134(3):653-7. PubMed ID: 4393622
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both.
    Murase N; Ye Q; Nalesnik MA; Demetris AJ; Abu-Elmagd K; Reyes J; Ichikawa N; Okuda T; Fung JJ; Starzl TE
    Transplantation; 2000 Dec; 70(11):1632-41. PubMed ID: 11152226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graft-versus-host reactivity and graft-versus-leukemia effect in murine allogeneic bone marrow chimeras conditioned with total body irradiation or total lymphoid irradiation.
    Salam A; Waer M
    Transplantation; 1996 Mar; 61(5):826-30. PubMed ID: 8607190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras.
    Jones JM; Wilson R; Bealmear PM
    Radiat Res; 1971 Mar; 45(3):577-88. PubMed ID: 4396814
    [No Abstract]   [Full Text] [Related]  

  • 37. Specific immunosuppression by postoperative infusion of allogeneic spleen cells: requirement of donor major histocompatibility complex expression and graft-versus-host reactivity.
    Tsui TY; Deiwick A; Ko S; Schlitt HJ
    Transplantation; 2000 Jan; 69(1):25-30. PubMed ID: 10653375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressor cells in transplantation tolerance. III. The role of antigen in the maintenance of transplantation tolerance.
    Tutschka PJ; Hess AD; Beschorner WE; Santos GW
    Transplantation; 1982 May; 33(5):510-4. PubMed ID: 6211807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide.
    Sharkis SJ; Santos GW; Colvin M
    Blood; 1980 Mar; 55(3):521-3. PubMed ID: 6986920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of tolerance to third-party donor organs in canine radiation chimeras.
    Rapaport FT; Bachvaroff RJ; Watanabe K; Cannon FD; Ayvazian JH; Blumenstock D; Ferrebee JW
    Transplant Proc; 1975 Dec; 7(4):471-4. PubMed ID: 826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.